#METABOLOMICS WORKBENCH hormel101_20160722_082113 DATATRACK_ID:684 STUDY_ID:ST000433 ANALYSIS_ID:AN000683
VERSION             	1
CREATED_ON             	July 29, 2016, 2:44 pm
#PROJECT
PR:PROJECT_TITLE                 	Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's
PR:PROJECT_TITLE                 	pathology
PR:PROJECT_TYPE                  	targeted sphingolipid and fatty acid analyses
PR:PROJECT_SUMMARY               	The clinical and pathological phenotypes of Dementia with Lewy bodies (DLB) and
PR:PROJECT_SUMMARY               	Alzheimer's disease (AD) often overlap. We examined whether plasma lipids
PR:PROJECT_SUMMARY               	differed among individuals with autopsy-confirmed Lewy Body pathology or AD
PR:PROJECT_SUMMARY               	pathology.
PR:INSTITUTE                     	Mayo Clinic
PR:DEPARTMENT                    	Department of Neurology
PR:LABORATORY                    	Mayo Metabolomics Core
PR:LAST_NAME                     	Mielke
PR:FIRST_NAME                    	Michelle
PR:ADDRESS                       	200 First Street SW, Rochester, MN 55905
PR:EMAIL                         	Mielke.Michelle@mayo.edu
PR:PHONE                         	507-293-1069
#STUDY
ST:STUDY_TITLE                   	Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's
ST:STUDY_TITLE                   	pathology
ST:STUDY_TYPE                    	targeted sphingolipid and fatty acid analyses
ST:STUDY_SUMMARY                 	We identified four groups with available plasma 2 years before death: high (n =
ST:STUDY_SUMMARY                 	12) and intermediate-likelihood DLB (n = 14) based on the third report of the
ST:STUDY_SUMMARY                 	DLB consortium; dementia with Alzheimer's pathology (AD; n = 18); and
ST:STUDY_SUMMARY                 	cognitively normal with normal aging pathology (n = 21). Lipids were measured
ST:STUDY_SUMMARY                 	using ESI/MS/MS.
ST:INSTITUTE                     	Mayo Clinic
ST:DEPARTMENT                    	Department of Neurology
ST:LABORATORY                    	Mayo Clinic Metabolomics Resource Core
ST:LAST_NAME                     	Mielke
ST:FIRST_NAME                    	Michelle
ST:ADDRESS                       	200 First Street SW, Rochester, MN 55905
ST:EMAIL                         	Mielke.Michelle@mayo.edu
ST:PHONE                         	507-293-1069
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	subject_1	sample1	Group:Cognitively normal	Sex=MALE; blood draw_age=78
SUBJECT_SAMPLE_FACTORS           	subject_2	sample2	Group:Cognitively normal	Sex=MALE; blood draw_age=86
SUBJECT_SAMPLE_FACTORS           	subject_3	sample3	Group:Cognitively normal	Sex=MALE; blood draw_age=78
SUBJECT_SAMPLE_FACTORS           	subject_4	sample4	Group:Cognitively normal	Sex=MALE; blood draw_age=92
SUBJECT_SAMPLE_FACTORS           	subject_5	sample5	Group:Cognitively normal	Sex=MALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_6	sample6	Group:Cognitively normal	Sex=MALE; blood draw_age=73
SUBJECT_SAMPLE_FACTORS           	subject_7	sample7	Group:Cognitively normal	Sex=MALE; blood draw_age=86
SUBJECT_SAMPLE_FACTORS           	subject_8	sample8	Group:Cognitively normal	Sex=MALE; blood draw_age=89
SUBJECT_SAMPLE_FACTORS           	subject_9	sample9	Group:Cognitively normal	Sex=MALE; blood draw_age=83
SUBJECT_SAMPLE_FACTORS           	subject_10	sample10	Group:Cognitively normal	Sex=MALE; blood draw_age=82
SUBJECT_SAMPLE_FACTORS           	subject_11	sample11	Group:Cognitively normal	Sex=MALE; blood draw_age=81
SUBJECT_SAMPLE_FACTORS           	subject_12	sample12	Group:Cognitively normal	Sex=MALE; blood draw_age=92
SUBJECT_SAMPLE_FACTORS           	subject_13	sample13	Group:Cognitively normal	Sex=MALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_14	sample14	Group:Cognitively normal	Sex=MALE; blood draw_age=91
SUBJECT_SAMPLE_FACTORS           	subject_15	sample15	Group:Cognitively normal	Sex=MALE; blood draw_age=88
SUBJECT_SAMPLE_FACTORS           	subject_16	sample16	Group:Cognitively normal	Sex=MALE; blood draw_age=81
SUBJECT_SAMPLE_FACTORS           	subject_17	sample17	Group:Cognitively normal	Sex=FEMALE; blood draw_age=80
SUBJECT_SAMPLE_FACTORS           	subject_18	sample18	Group:Cognitively normal	Sex=FEMALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_19	sample19	Group:Cognitively normal	Sex=FEMALE; blood draw_age=77
SUBJECT_SAMPLE_FACTORS           	subject_20	sample20	Group:Cognitively normal	Sex=FEMALE; blood draw_age=74
SUBJECT_SAMPLE_FACTORS           	subject_21	sample21	Group:Cognitively normal	Sex=FEMALE; blood draw_age=81
SUBJECT_SAMPLE_FACTORS           	subject_22	sample22	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=85
SUBJECT_SAMPLE_FACTORS           	subject_23	sample23	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=76
SUBJECT_SAMPLE_FACTORS           	subject_24	sample24	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=74
SUBJECT_SAMPLE_FACTORS           	subject_25	sample25	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=71
SUBJECT_SAMPLE_FACTORS           	subject_26	sample26	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=81
SUBJECT_SAMPLE_FACTORS           	subject_27	sample27	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_28	sample28	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=80
SUBJECT_SAMPLE_FACTORS           	subject_29	sample29	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=70
SUBJECT_SAMPLE_FACTORS           	subject_30	sample30	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=73
SUBJECT_SAMPLE_FACTORS           	subject_31	sample31	Group:Dementia with Lewy Bodies	Sex=MALE; blood draw_age=84
SUBJECT_SAMPLE_FACTORS           	subject_32	sample32	Group:Dementia with Lewy Bodies	Sex=FEMALE; blood draw_age=-
SUBJECT_SAMPLE_FACTORS           	subject_33	sample33	Group:Dementia with Lewy Bodies	Sex=FEMALE; blood draw_age=74
SUBJECT_SAMPLE_FACTORS           	subject_34	sample34	Group:Dementia with Lewy Bodies	Sex=FEMALE; blood draw_age=79
SUBJECT_SAMPLE_FACTORS           	subject_35	sample35	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=89
SUBJECT_SAMPLE_FACTORS           	subject_36	sample36	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=81
SUBJECT_SAMPLE_FACTORS           	subject_37	sample37	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=81
SUBJECT_SAMPLE_FACTORS           	subject_38	sample38	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=80
SUBJECT_SAMPLE_FACTORS           	subject_39	sample39	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=73
SUBJECT_SAMPLE_FACTORS           	subject_40	sample40	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=73
SUBJECT_SAMPLE_FACTORS           	subject_41	sample41	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=72
SUBJECT_SAMPLE_FACTORS           	subject_42	sample42	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=70
SUBJECT_SAMPLE_FACTORS           	subject_43	sample43	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=71
SUBJECT_SAMPLE_FACTORS           	subject_44	sample44	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=73
SUBJECT_SAMPLE_FACTORS           	subject_45	sample45	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=83
SUBJECT_SAMPLE_FACTORS           	subject_46	sample46	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=76
SUBJECT_SAMPLE_FACTORS           	subject_47	sample47	Group:Mixed DLB and AD	Sex=MALE; blood draw_age=71
SUBJECT_SAMPLE_FACTORS           	subject_48	sample48	Group:Mixed DLB and AD	Sex=FEMALE; blood draw_age=92
SUBJECT_SAMPLE_FACTORS           	subject_49	sample49	Group:Mixed DLB and AD	Sex=FEMALE; blood draw_age=88
SUBJECT_SAMPLE_FACTORS           	subject_50	sample50	Group:Mixed DLB and AD	Sex=FEMALE; blood draw_age=92
SUBJECT_SAMPLE_FACTORS           	subject_51	sample51	Group:Mixed DLB and AD	Sex=FEMALE; blood draw_age=86
SUBJECT_SAMPLE_FACTORS           	subject_52	sample52	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=85
SUBJECT_SAMPLE_FACTORS           	subject_53	sample53	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=82
SUBJECT_SAMPLE_FACTORS           	subject_54	sample54	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=87
SUBJECT_SAMPLE_FACTORS           	subject_55	sample55	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=86
SUBJECT_SAMPLE_FACTORS           	subject_56	sample56	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=84
SUBJECT_SAMPLE_FACTORS           	subject_57	sample57	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=80
SUBJECT_SAMPLE_FACTORS           	subject_58	sample58	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=84
SUBJECT_SAMPLE_FACTORS           	subject_59	sample59	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=78
SUBJECT_SAMPLE_FACTORS           	subject_60	sample60	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_61	sample61	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=78
SUBJECT_SAMPLE_FACTORS           	subject_62	sample62	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=82
SUBJECT_SAMPLE_FACTORS           	subject_63	sample63	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=71
SUBJECT_SAMPLE_FACTORS           	subject_64	sample64	Group:Alzheimer's disease dementia	Sex=MALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_65	sample65	Group:Alzheimer's disease dementia	Sex=FEMALE; blood draw_age=78
SUBJECT_SAMPLE_FACTORS           	subject_66	sample66	Group:Alzheimer's disease dementia	Sex=FEMALE; blood draw_age=75
SUBJECT_SAMPLE_FACTORS           	subject_67	sample67	Group:Alzheimer's disease dementia	Sex=FEMALE; blood draw_age=70
SUBJECT_SAMPLE_FACTORS           	subject_68	sample68	Group:Alzheimer's disease dementia	Sex=FEMALE; blood draw_age=74
SUBJECT_SAMPLE_FACTORS           	subject_69	sample69	Group:Alzheimer's disease dementia	Sex=FEMALE; blood draw_age=76
#COLLECTION
CO:COLLECTION_SUMMARY            	All blood samples in the Mayo Clinic ADRC are collected from nonfasting
CO:COLLECTION_SUMMARY            	participants in the sitting position in a clinical laboratory. Serum tubes
CO:COLLECTION_SUMMARY            	(red-top) are drawn first, followed by EDTA plasma tubes. Blood is drawn from
CO:COLLECTION_SUMMARY            	the median cubital vein with a 21 g needle and typically centrifuged at 2000 g
CO:COLLECTION_SUMMARY            	for 10 minutes at 4°C. The serum and plasma are aliquoted into 0.5 mL and
CO:COLLECTION_SUMMARY            	stored in a −80°C freezer until use. None of the aliquots were thawed before
CO:COLLECTION_SUMMARY            	being pulled to measure the sphingolipids and fatty acids. We have previously
CO:COLLECTION_SUMMARY            	shown that long-term storage, up to 38 years, in long-term −80°C freezers
CO:COLLECTION_SUMMARY            	does not affect sphingolipid levels [26].
#TREATMENT
TR:TREATMENT_SUMMARY             	All individuals were enrolled in the Mayo Clinic Alzheimer's Disease Research
TR:TREATMENT_SUMMARY             	Center (ADRC) and donated their brain to the Neuropathology Core. Eligibility
TR:TREATMENT_SUMMARY             	criteria for the proposed study included an autopsy report and available blood
TR:TREATMENT_SUMMARY             	at the last study visit before death. Standardized methods for sampling and
TR:TREATMENT_SUMMARY             	neuropathologic examination were performed according to the third report of the
TR:TREATMENT_SUMMARY             	DLB consortium (CDLB) [20], [21] and the Consortium to Establish a Registry for
TR:TREATMENT_SUMMARY             	Alzheimer's Disease guidelines [22]. Braak neurofibrillary tangle (NFT) stage
TR:TREATMENT_SUMMARY             	was determined based on the distribution of NFTs assessed with Bielschowsky
TR:TREATMENT_SUMMARY             	silver stain [23]. A consensus clinical diagnosis was determined at each study
TR:TREATMENT_SUMMARY             	visit by a panel of neurologists, neuropsychologists, and nurses who reviewed
TR:TREATMENT_SUMMARY             	all patient information including neuropsychological results, activities of
TR:TREATMENT_SUMMARY             	daily living, and the Clinical Dementia Rating scale. The diagnosis of dementia
TR:TREATMENT_SUMMARY             	was based on DSM-III-R criteria [24]. We identified the following four groups:
TR:TREATMENT_SUMMARY             	(1) Cognitively normal-normal pathology [CN, n = 21]. These individuals had no
TR:TREATMENT_SUMMARY             	LBs, had low-likelihood AD according to the National Institute of Aging
TR:TREATMENT_SUMMARY             	(NIA)-Reagan Criteria [25], and were cognitively normal as of their last study
TR:TREATMENT_SUMMARY             	visit. (2) High-likelihood DLB [n = 13]. These individuals met criteria for
TR:TREATMENT_SUMMARY             	high-likelihood DLB according to the CDLB, had Braak NFT stage ≤ IV, low to
TR:TREATMENT_SUMMARY             	intermediate-likelihood AD, and a diagnosis of dementia as of the last study
TR:TREATMENT_SUMMARY             	visit. Twelve patients had diffuse LB and one had transitional LB. (3)
TR:TREATMENT_SUMMARY             	Intermediate-likelihood DLB (n = 17). These individuals had both DLB and AD
TR:TREATMENT_SUMMARY             	pathologies. They had transitional (n = 14) or diffuse (n = 3) LBs, met criteria
TR:TREATMENT_SUMMARY             	for intermediate-likelihood DLB according to the CDLB, had Braak NFT stage ≥
TR:TREATMENT_SUMMARY             	IV, intermediate to high-likelihood AD, and a diagnosis of dementia as of the
TR:TREATMENT_SUMMARY             	last study visit. (4) Alzheimer's disease pathology (AD, n = 18). These
TR:TREATMENT_SUMMARY             	individuals had high (n = 16) or intermediate (n = 2) likelihood AD according to
TR:TREATMENT_SUMMARY             	NIA-Reagan criteria, had Braak NFT stage ≥ IV, no LBs, and had a diagnosis of
TR:TREATMENT_SUMMARY             	probable AD dementia. Given our previous report that plasma ceramides increase
TR:TREATMENT_SUMMARY             	with age and are higher in women [26], we frequency matched the four groups by
TR:TREATMENT_SUMMARY             	sex and also by age.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The lipids were extracted from 200 μL of plasma after the addition of internal
SP:SAMPLEPREP_SUMMARY            	standards.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY     	The targeted sphingolipid and fatty acid analyses were conducted by the Mayo
CH:CHROMATOGRAPHY_SUMMARY     	Clinic Metabolomics Core. Electrospray ionization mass spectrometry was used to
CH:CHROMATOGRAPHY_SUMMARY     	quantify plasma ceramides, sphinganine, sphingosine, sphingosine-1-phosphate
CH:CHROMATOGRAPHY_SUMMARY     	(S1P), monohexosylceramides, and free fatty acids. The lipids were extracted
CH:CHROMATOGRAPHY_SUMMARY     	from 200 μL of plasma after the addition of internal standards. The extracts
CH:CHROMATOGRAPHY_SUMMARY     	were measured against a standard curve on the Thermo TSQ Quantum Ultra mass
CH:CHROMATOGRAPHY_SUMMARY     	spectrometer (West Palm Beach, FL) coupled with a Waters Acquity UPLC system
CH:CHROMATOGRAPHY_SUMMARY     	(Milford, MA) and quantified in μM units.
CH:CHROMATOGRAPHY_TYPE        	UPLC
CH:INSTRUMENT_NAME            	Thermo TSQ Quantum Ultra
CH:COLUMN_NAME                	NONE
#ANALYSIS
AN:ANALYSIS_TYPE            	MS
#MS
MS:INSTRUMENT_NAME          	Thermo TSQ Quantum Ultra
MS:INSTRUMENT_TYPE          	Triple quadrupole
MS:MS_TYPE                  	ESI
MS:ION_MODE                 	POSITIVE
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	micromolar
MS_METABOLITE_DATA_START
Samples	sample1	sample2	sample3	sample4	sample5	sample6	sample7	sample8	sample9	sample10	sample11	sample12	sample13	sample14	sample15	sample16	sample17	sample18	sample19	sample20	sample21	sample22	sample23	sample24	sample25	sample26	sample27	sample28	sample29	sample30	sample31	sample32	sample33	sample34	sample35	sample36	sample37	sample38	sample39	sample40	sample41	sample42	sample43	sample44	sample45	sample46	sample47	sample48	sample49	sample50	sample51	sample52	sample53	sample54	sample55	sample56	sample57	sample58	sample59	sample60	sample61	sample62	sample63	sample64	sample65	sample66	sample67	sample68	sample69
Factors	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Cognitively normal	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Dementia with Lewy Bodies	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Mixed DLB and AD	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia	Group:Alzheimer's disease dementia
sph	0.005	0.013	0.005	0.015	0.004	0.002	0.003	0.008	0.01	0.011	0.006	0.012	0.011	0.004	0.029	0.007	0.003	0.004	0.012	0.01	0.01	0.018	0.003	0.003	0.006	0.003	0.005	0.032	0.009	0.014	0.005	0.006	0.006	0.005	0.006	0.011	0.005	0.009	0.003	0.01	0.007	0.009	0.002	0.006	0.012	0.011	0.006	0.011	0.017	0.007	0.015	0.009	0.012	0.004	0.004	0.004	0.006	0.018	0.002	0.011	0.011	0.004	0.008	0.007	0.004	0.005	0.003	0.012	0.008
spa	0.004	0.011	0.007	0.009	0.004	0.003	0.004	0.007	0.008	0.005	0.004	0.012	0.013	0.005	0.016	0.007	0.005	0.004	0.012	0.013	0.007	0.008	0.002	0.004	0.004	0.003	0.004	0.028	0.007	0.011	0.006	0.004	0.007	0.004	0.005	0.008	0.004	0.008	0.004	0.007	0.007	0.008	0.004	0.005	0.012	0.008	0.006	0.007	0.014	0.008	0.013	0.007	0.008	0.006	0.006	0.005	0.006	0.01	0.002	0.008	0.005	0.004	0.006	0.007	0.005	0.003	0.005	0.011	0.011
s1p	2.16	3.38	2.41	1.32	1.72	1.41	0.63	1.04	0.96	1.17	1.27	3.04	3.73	3.34	4.1	2.04	0.96	2.26	3.97	5.09	1.14	2.21	1.77	2.34	2.25	1.51	2.04	0.23	2.88	1.85	3.39	1.9	1.18	2.28	1	3.01	1.6	4	2.57	2.03	1.24	2.19	1.38	2.48	3.47	3.92	3.65	3.99	4.83	3.47	4	4.37	2.92	2.06	0.77	1.92	2.14	2.42	0.84	3.74	1.18	1.45	3.13	1.71	2.8	2.44	2.16	1.19	3.54
cer140	0.026	0.03	0.044	0.011	0.027	0.062	0.032	0.016	0.039	0.017	0.031	0.019	0.029	0.02	0.038	0.041	0.021	0.025	0.041	0.046	0.026	0.034	0.034	0.057	0.029	0.046	0.025	0.085	0.023	0.026	0.027	0.034	0.05	0.042	0.052	0.044	0.019	0.02	0.028	0.031	0.026	0.031	0.033	0.03	0.038	0.024	0.033	0.02	0.02	0.03	0.026	0.04	0.027	0.025	0.04	0.023	0.035	0.027	0.044	0.046	0.022	0.025	0.021	0.026	0.028	0.025	0.023	0.058	0.029
cer160	0.351	0.517	0.621	0.467	0.377	0.931	0.504	0.219	0.34	0.496	0.452	0.457	0.436	0.336	0.409	0.481	0.541	0.503	0.602	0.608	0.336	0.53	0.603	0.716	0.412	0.775	0.461	1.406	0.546	0.631	0.499	0.618	0.655	0.491	0.567	0.738	0.346	0.435	0.264	0.489	0.372	0.524	0.499	0.571	0.572	0.45	0.442	0.552	0.365	0.706	0.489	0.6	0.475	0.55	0.514	0.681	0.563	0.576	0.579	0.927	0.746	0.513	0.351	0.32	0.491	0.482	0.638	0.747	0.637
cer181	0.009	0.009	0.02	0.016	0.015	0.07	0.023	0.017	0.023	0.03	0.022	0.014	0.023	0.018	0.021	0.028	0.028	0.031	0.031	0.024	0.023	0.051	0.033	0.029	0.033	0.039	0.02	0.213	0.015	0.057	0.022	0.034	0.042	0.025	0.03	0.069	0.017	0.013	0.013	0.027	0.016	0.032	0.038	0.025	0.029	0.022	0.02	0.032	0.024	0.019	0.028	0.02	0.021	0.029	0.028	0.033	0.019	0.026	0.04	0.033	0.035	0.021	0.026	0.023	0.045	0.036	0.034	0.054	0.036
cer180	0.05	0.05	0.1	0.09	0.06	0.18	0.06	0.06	0.08	0.18	0.07	0.07	0.1	0.05	0.09	0.09	0.12	0.11	0.13	0.08	0.08	0.16	0.13	0.08	0.1	0.15	0.09	0.57	0.07	0.15	0.07	0.13	0.13	0.08	0.12	0.28	0.06	0.07	0.05	0.11	0.06	0.11	0.11	0.08	0.12	0.09	0.06	0.11	0.06	0.14	0.13	0.09	0.07	0.11	0.11	0.11	0.07	0.1	0.16	0.15	0.22	0.09	0.07	0.06	0.12	0.17	0.09	0.19	0.13
cer200	0.1	0.14	0.18	0.08	0.12	0.38	0.13	0.09	0.13	0.23	0.18	0.13	0.22	0.11	0.25	0.17	0.19	0.21	0.23	0.18	0.14	0.34	0.3	0.27	0.19	0.25	0.13	0.36	0.11	0.24	0.17	0.19	0.24	0.16	0.2	0.48	0.1	0.12	0.11	0.16	0.11	0.17	0.19	0.12	0.21	0.16	0.14	0.2	0.08	0.19	0.21	0.18	0.15	0.22	0.24	0.24	0.2	0.21	0.3	0.38	0.28	0.13	0.18	0.12	0.27	0.27	0.2	0.3	0.27
cer241	0.56	0.73	0.87	0.85	0.96	1.11	0.58	0.39	0.74	0.9	0.64	0.76	0.97	0.6	0.99	0.88	0.79	1.44	1.07	0.8	0.7	1.89	1.3	1.36	1.19	1.75	0.78	0.76	0.84	1.51	0.64	1.06	0.98	0.74	0.82	1.82	0.71	0.72	0.62	0.65	0.5	0.87	0.84	0.6	0.71	1.07	0.84	0.9	0.49	0.93	0.78	0.61	0.63	1.1	1.08	1.24	0.82	1.16	1.2	1.3	1	0.92	0.55	0.61	1.04	1.69	1.13	1.01	1.23
cer240	2	2.12	2.61	0.55	2.94	6.27	2.47	0.87	2.02	1.36	2.34	2.13	1.75	1.9	4.11	2.43	1.97	2.34	3.37	3.18	2.4	2.69	2.64	2.33	2.06	3.32	1.27	1.07	1.12	2.55	2.33	1.41	3.45	1.7	2.14	2.93	1.48	1.75	1.68	1.73	1.37	3.25	3.31	1.31	2.59	2.09	2.23	1.89	1.21	2.26	1.78	2.18	1.54	2.27	3.36	2.63	2.77	2.5	1.82	4.98	1.17	1.59	1.87	1.82	4.59	1.99	2.77	2.97	3.16
linolenic	0.53	1.11	4.71	1.36	2.77	1.44	1.25	4.59	3.85	3.3	5.95	2.67	2.96	5.31	7.14	2.88	0.37	1.9	4.38	6.8	2.71	2.5	7.87	2.16	5.37	1.8	0.61	29.35	6.76	3.59	2.98	4.69	12.26	0.82	1.09	7.9	2.3	1	3.29	3.54	4.96	1.4	1.12	0.7	2.77	1.41	1.36	2.86	4.7	1.11	1.88	3.36	1.82	0.68	0.95	1.12	0.81	0.71	3.19	2.85	4.44	0.72	2.62	4.03	4.63	3.05	2.07	9.4	1.6
myristic	2.32	5.5	7.73	5.8	4.25	4.41	4.1	6.55	9.95	8.53	9.06	11.09	11.75	19.67	15.63	12.96	1.73	3.28	23.88	31.58	8.57	28.08	8.19	8.37	15.78	2.04	3.79	39.06	18.84	10.35	3.04	24.45	29.37	7.76	4.32	21	3.69	4.73	11.71	10.03	7.69	5.97	7.42	7.71	7.91	2.8	6.82	10.29	14.36	2.95	7.2	5.58	3.84	2.48	2.23	2.18	3.03	3	12.29	16.65	13.99	1.98	2.28	7.91	9.1	13.56	5.65	28.21	10.33
palmitoleic	1.93	3.91	3.99	5.37	2.54	2.7	2.32	5.84	5.18	10.03	7.85	11.38	9.55	17.57	12.41	10.71	1.35	3.61	22.81	35.36	9.57	16.53	10.13	7.12	14.24	2.02	1.65	37.4	19.62	7.48	1.34	27	29.95	1.99	2.58	20.5	2.92	2.11	8.16	5.61	7.61	2.45	2.79	1.49	4.87	2.34	1.89	7.06	10.71	2.3	3.7	2.22	3.4	1.34	2.53	2.32	2.01	2.58	14.96	9.17	12.7	1.35	1.62	6.15	8.22	18.47	4.39	11.7	8.81
arachidonic	1.1	0.91	2.18	1.24	1.52	1.03	0.72	1	0.85	0.95	1.58	0.88	1.33	1.04	0.91	1.13	0.7	1.15	0.97	0.75	0.9	0.98	1.81	0.78	1.39	1.12	1.12	32.71	1.69	1.05	0.62	1.02	1.7	0.92	0.88	1.04	1.17	0.91	0.73	0.6	1.12	1.03	1.11	0.9	0.93	1	0.66	0.67	0.54	1.05	1.1	0.75	0.97	0.75	0.78	1.14	1.3	0.96	2.57	0.95	1.31	1.14	0.76	0.93	1.2	1.58	1.12	1.2	0.98
linoleic	4.06	14.45	36.1	19.69	24.82	17.81	16.23	29.05	34.35	36.92	60.4	29.39	26.01	48.19	52.88	31.1	7.09	13.95	50.08	73.07	26.88	34.88	64.5	20.74	38.77	14.42	7.33	269.24	67.84	36.68	20.8	52.82	100.78	5.46	12.37	69.93	13.53	8.37	33.53	30.92	35.61	14.13	9.26	6.32	21.85	12.33	11.85	30.31	40.93	8.97	15.98	24.68	22.44	9.24	10.01	13.18	7.74	6.02	32.6	35.91	59.6	6.55	21.79	34.01	43.16	37.05	20.96	57.47	18.52
palmitic	19.97	69.92	81.98	73.33	51.84	48.29	40.36	69.77	91.1	119.49	103.77	114.8	90.32	152.98	130.37	129.04	21.05	24.96	219.54	210.64	75.54	217.78	101.55	71.9	97.82	30.2	30.22	444.17	157.88	114.27	40.86	171.94	228.79	32.32	29.98	170.69	41.73	42.86	95.28	79.59	65.98	66.18	42.21	65.93	65.72	42.04	48.21	100.88	130.21	35.01	55.72	52.96	68.02	26.87	28.5	31.12	23.72	40.34	100.3	150.63	122.86	20.2	40.55	104.59	86.81	147.5	56.74	147.7	100.88
oleic	15.88	56.87	86.29	79.7	55.39	49.91	31.35	64.15	78.31	111.85	126.81	108.96	80.97	137.68	111.12	123.53	14.96	29.97	177.55	267.93	73.93	207.19	123.29	70.45	134.31	34.54	24.41	306.46	193.43	117.44	28.91	214.53	280.36	23.89	22.24	241.42	28.32	25.55	107.15	61.03	66.73	42.3	33.96	23.61	39.72	32.03	24.77	83.53	104.27	20.68	33.87	35.72	52.53	17.5	25.07	36.46	21.67	21.44	89.46	126.45	134.53	20.82	31.26	99.16	102.05	170.05	66.66	130.59	83.38
elaidic	2.21	7.36	33.71	8.49	9.93	15.24	6.06	5.51	9.61	8.66	8.44	8.14	8.48	9.51	7.42	10.62	2.79	3.72	13.11	17.24	6.98	20.84	21.81	10.25	11.72	6.11	2.27	29.44	22.08	16	3.47	24.03	26.25	2.03	4.04	36.18	2.37	4.19	7.45	6.05	4.84	7.82	4.91	4.68	3.7	2.46	2.46	12.35	15.62	2.86	2.8	6.03	4.72	3	3.56	6.76	2.69	3.38	7.03	17.48	15.02	4.86	10.27	13.75	15.87	18.12	14.08	28.24	9.2
stearic	5.73	31.55	53.9	38.97	26.91	33.43	14.44	22.1	22.22	34.19	30.2	41.91	38.09	49.95	32.85	43.17	7.76	8.56	68.22	64.27	22.75	80.92	45.49	25.42	38.78	13.06	13.28	96.19	59.76	48.21	14.17	58.51	88.78	10.72	10.87	55.03	13.09	16.77	28.44	21.94	18.47	31.43	18.94	34.29	21.85	16.1	17.05	33.79	36.82	15.97	21.41	24.11	32.27	9.56	9.29	17.62	9.87	11.78	33.48	54.48	36.75	9.58	19.1	36.83	35.21	53.7	24.83	64.53	32.28
c180hexcerum	0.216	0.111	0.171	0.08	0.112	0.263	0.144	0.054	0.183	0.179	0.107	0.236	0.222	0.275	0.129	0.192	0.323	0.271	0.272	0.288	0.072	0.453	0.233	0.137	0.235	0.187	0.246	0.195	0.144	0.554	0.206	0.311	0.33		0.328	0.138	0.061	0.182	0.127	0.165	0.123	0.252	0.239	0.181	0.151	0.184	0.161	0.186	0.174	0.236	0.229	0.248	0.168	0.207	0.237	0.209	0.333	0.102	0.274	0.228	0.246	0.186	0.131	0.157	0.2	0.632	0.322	0.32	0.209
c181hexcerum	0.017	0.013	0.016	0.007	0.01	0.027	0.024	0.006	0.02	0.013	0.009	0.012	0.013	0.012	0.01	0.011	0.029	0.034	0.013	0.02	0.009	0.023	0.044	0.024	0.016	0.038	0.018	0.02	0.013	0.046	0.026	0.041	0.018		0.048	0.028	0.005	0.019	0.012	0.012	0.01	0.016	0.014	0.012	0.008	0.01	0.014	0.024	0.024	0.023	0.015	0.022	0.011	0.024	0.026	0.024	0.036	0.006	0.018	0.022	0.022	0.015	0.017	0.019	0.031	0.04	0.035	0.024	0.02
c241hexcerum	1.047	0.454	0.641	0.597	0.414	0.568	0.478	0.233	0.713	0.767	0.339	0.677	0.823	0.782	0.648	0.623	0.981	1.008	0.678	0.773	0.458	1.592	0.848	0.927	1.014	0.78	1.061	0.549	0.761	1.685	0.834	1.083	0.786		0.964	0.66	0.708	0.729	0.733	0.741	0.627	0.614	0.955	0.792	0.481	1.244	0.886	0.751	0.719	0.886	0.776	0.831	0.629	0.755	0.97	0.926	1.22	0.635	1.25	0.706	0.651	1.755	0.56	0.489	0.701	1.193	0.832	0.881	0.809
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name
sph
spa
s1p
cer140
cer160
cer181
cer180
cer200
cer241
cer240
linolenic
myristic
palmitoleic
arachidonic
linoleic
palmitic
oleic
elaidic
stearic
c180hexcerum
c181hexcerum
c241hexcerum
METABOLITES_END
#END
